Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibrx Biosciences (INBX) Assets: 2023-2024

Historic Assets for Inhibrx Biosciences (INBX) over the last 2 years, with Dec 2024 value amounting to $180.8 million.

  • Inhibrx Biosciences' Assets fell 20.26% to $177.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $177.5 million, marking a year-over-year decrease of 20.26%. This contributed to the annual value of $180.8 million for FY2024, which is 41.29% down from last year.
  • Per Inhibrx Biosciences' latest filing, its Assets stood at $180.8 million for FY2024, which was down 41.29% from $307.9 million recorded in FY2023.
  • Over the past 5 years, Inhibrx Biosciences' Assets peaked at $307.9 million during FY2023, and registered a low of $180.8 million during FY2024.
  • For the 2-year period, Inhibrx Biosciences' Assets averaged around $244.3 million, with its median value being $244.3 million (2023).
  • Data for Inhibrx Biosciences' Assets shows a maximum YoY tumbled of 41.29% (in 2024) over the last 5 years.
  • Over the past 2 years, Inhibrx Biosciences' Assets (Yearly) stood at $307.9 million in 2023, then crashed by 41.29% to $180.8 million in 2024.